Bailard’s National Healthcare NHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,280
Closed -$450K 796
2025
Q4
$450K Buy
+3,280
New +$424K 0.01% 493
2020
Q3
Sell
-4,177
Closed -$265K 602
2020
Q2
$265K Buy
4,177
+500
+14% +$33.5K 0.01% 387
2020
Q1
$264K Buy
+3,677
New +$291K 0.02% 351
2019
Q4
Sell
-4,760
Closed -$390K 583
2019
Q3
$390K Buy
+4,760
New +$394K 0.02% 334
2019
Q1
Sell
-5,200
Closed -$408K 577
2018
Q4
$408K Sell
5,200
-3,600
-41% -$282K 0.03% 346
2018
Q3
$663K Buy
+8,800
New +$647K 0.04% 290

Other funds holding NHC

Bailard's NHC Position: Q1 2026 in Review

Bailard sold out of National Healthcare (NHC) in Q1 2026, closing a stake of 3,280 shares — an estimated $450K sold.

Bailard first reported a position in NHC in Q3 2018 and held it in 6 quarters. The position peaked at $663K in Q3 2018. 238 funds tracked by Wall St. Rank hold NHC as of Q1 2026.

  • Bailard reported no remaining National Healthcare position as of Q1 2026 after selling out during the quarter.
  • Bailard sold 3,280 National Healthcare shares in Q1 2026, an estimated $450K.
  • Bailard first reported a position in National Healthcare in Q3 2018 and held it in 6 quarters.
  • Bailard's National Healthcare position peaked at $663K in Q3 2018.
  • 238 funds tracked by Wall St. Rank held National Healthcare as of Q1 2026.

Based on Bailard's 13F filing for Q1 2026, filed 11 May 2026.